Article
Increased titer of anti-beta2-glycoprotein I IgG antibody among factor V Leiden carriers during oral contraceptive use.
Contraception - 1 Jan 2004
Póka R, Vad S, Lakos G, Bereczki Z, Kiss E, Sipka S
Abstract excerpt
The risk of thromboembolism during oral contraceptive (OC) use is increased among factor V Leiden (FVL) carriers compared to women with wild-type genotype of the gene for coagulation factor V (FV). The carrier frequency in the general population is too high for FVL alone to be responsible for the reported association. Additional risk factors may be required to explain the increased risk of thromboembolism of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
